Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.38 |
| ▸ | CDK9 | P50750 | 2/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.37 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PTK2 | Q05397 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3375825 | 0.90 | TSHR (0.50) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL11209538 | 0.86 | F2 (0.38) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL917064 | 0.85 | NPY5R (0.42) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL16062693 | 0.84 | POLB (0.46) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL2493713 | 0.84 | TSHR (0.44) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL23822678 | 0.82 | TSHR (0.43) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL915242 | 0.82 | TSHR (0.43) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL25923558 | 0.82 | TSHR (0.43) | NPY5RTSHRCCNT1CDK9TLR8 | |
| SCHEMBL9502876 | 0.82 | CCNT1 (0.42) | NPY5RTSHRCCNT1CDK9HDAC1 | |
| SCHEMBL13981576 | 0.81 | NPY5R (0.42) | NPY5RTSHRCCNT1CDK9TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122039051-A | Composite coating for high-wear-resistance sliding bearing and preparation method thereof | 成都工业职业技术学院 | 2026-05-15 | — | — | CN | disclosed |
| WO-2020160333-A1 | ENPP1 INHIBITORS AND METHODS OF MODULATING IMMUNE RESPONSE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2020-08-06 | — | — | WO | disclosed |
| EP-1810681-B1 | INTESTINAL POLYP INHIBITOR | NAT CANCER CT (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-7572775-B2 | Method of inhibiting intestinal polyps | JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF AGENCY OF NATIONAL CANCER CENTER (JP) | 2009-08-11 | — | — | US | disclosed |
| US-20080139516-A1 | Intestinal Polyp Inhibitor | JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF AGENCY OF NATIONAL CANCER CENTER (JP) | 2008-06-12 | — | — | US | disclosed |
| EP-1810681-A1 | INTESTINAL POLYP INHIBITOR | JAPAN as represented by DIRECTOR GENERAL OF AGENCY OF NACIONAL CANCER CENTER (JP) | 2007-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139516-A1 | Intestinal Polyp Inhibitor | APC, VIP, FAP | NPY5R 2052/4885TSHR 4349/4885CCNT1 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.